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Abstract
The insufficiency of compensatory angiogenesis in the heart of hypertension patients contributes 
to heart failure transition. The HIF1α-VEGF signaling cascade controls responsive angiogenesis. 
One of the challenges in reprograming the insufficient angiogenesis is to achieve a sustainable 
tissue exposure to the pro-angiogenic factors, such as HIF1α stabilization. In this study, we 
identified Rnd3, a small Rho GTPase, as a pro-angiogenic factor participating in the regulation of 
the HIF1α-VEGF signaling cascade. Rnd3 physically interacted with and stabilized HIF1α, and 
consequently promoted VEGFA expression and endothelial cell tube formation. To demonstrate 
this pro-angiogenic role of Rnd3 in vivo, we generated Rnd3 knockout mice. Rnd3 
haploinsufficient (Rnd3+/−) mice were viable, yet developed dilated cardiomyopathy with heart 
failure after transverse aortic constriction stress. The post-stress Rnd3+/− hearts showed 
significantly impaired angiogenesis and decreased HIF1α and VEGFA expression. The 
angiogenesis defect and heart failure phenotype were partially rescued by cobalt chloride 
treatment, a HIF1α stabilizer, confirming a critical role of Rnd3 in stress-responsive angiogenesis. 
Furthermore, we generated Rnd3 transgenic mice and demonstrated that Rnd3 overexpression in 
heart had a cardio-protective effect through reserved cardiac function and preserved responsive 
angiogenesis after pressure overload. Finally, we assessed the expression levels of Rnd3 in the 
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human heart and detected significant downregulation of Rnd3 in patients with end-stage heart 
failure. We concluded that Rnd3 acted as a novel pro-angiogenic factor involved in cardiac 
responsive angiogenesis through HIF1α-VEGFA signaling promotion. Rnd3 downregulation 
observed in heart failure patients may explain the insufficient compensatory angiogenesis involved 
in the transition to heart failure.
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Hypertension is one of the most prevalent myocardial stress factors for the development of 
heart failure. Neovascularization is a compensatory mechanism in the heart in response to 
hemodynamic stress. The compounding effect of the increased cardiac demand for oxygen 
and nutrients and responsive cardiac angiogenesis contributes to the transition into 
pathological adaption, eventually leading to heart failure.1–4 Activation of the cardiac 
angiogenesis program is a promising therapeutic strategy validated in multiple forms of 
cardiac disease animal models.5–8 The hypoxia-inducible factor 1α-vascular endothelial 
growth factor (HIF1α-VEGF) molecular signaling cascade is the most powerful and well-
studied signaling pathway in ischemia/hypoxia-induced angiogenesis. Preclinical animal 
studies using pro-angiogenic factors such as VEGF, HIF1α, and fibroblast growth factor 
(FGF) have achieved remarkable success.7–12 However, the translation of these animal 
studies to clinical therapy is intermittent, and the results are far from satisfactory.5, 6, 13, 14 
Several important lessons have been demonstrated in clinical trials. One of the challenges in 
clinical practice is to achieve sustainable tissue exposure to pro-angiogenic factors in order 
to achieve a prolonged stimulation. One possible solution is through the stabilization of 
HIF1α, which is unstable and quickly degraded by UPS (ubiquitin proteasome system) 
under normoxic conditions.5 Another challenge is to develop new patient-relevant animal 
models for basic research.5 Therefore, identifying a novel factor to stabilize key pro-
angiogenic factors as well as establishing a new animal model closely related to human heart 
failure are critical strategies for the resolution of the serious deficiency in currently available 
information pertaining to translational studies of angiogenesis involvement in heart failure.
Our recent study discovered that Rnd3, a small Rho GTPase also called RhoE, was a cardiac 
protective factor and protected the heart from pressure overload-induced heart failure. Mice 
with Rnd3 haploinsufficiency developed severe heart failure after pressure overload 
challenge.15 However, the associated molecular mechanism remains largely unknown. In 
this study, we demonstrated Rnd3 as an important proactive factor for adaptive myocardial 
angiogenesis in response to pressure overload. We revealed the molecular mechanism of 
Rnd3-mediated angiogenesis regulation through the stabilization of HIF1α, a key pro-
angiogenic transcriptional factor. The findings uncovered a new function of this small 
GTPase in the refinement of the HIF1α-VEGFA regulatory pathway, and provided a 
potential new target for pharmacological manipulation of HIF1α-VEGF signaling. The 
assessment of Rnd3 expression levels in patients could be a new reference biomarker for 
human heart failure.
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In summary, this study uncovered a pro-angiogenic function of Rnd3 in the regulation of the 
HIF1α-VEGFA signaling pathway. The decrease in Rnd3 expression levels contributed to 
the insufficiency of adaptive coronary angiogenesis in the mouse heart in response to 
hemodynamic stress. The discovery of a significant downregulation in Rnd3 levels in 
myocardia of heart failure patients implicated the translational and clinical significance of 
these findings.
Methods
Methods and associated references were provided in detail in the online supplement of the 
paper, which included the approval of animal protocol and human heart tissue usage, 
generation of the mutant mouse lines and assessments of cardiac function and angiogenesis.
Statistics
Data are expressed means ± s.d. In multiple group comparisons, one-way ANOVA followed 
by Student-Newman-Keuls method was used. In two group comparisons, unpaired, two-
tailed student’s t test was used. All of the analyses were conducted by SigmaPlot 11.0 
(Systat, San Jose, CA, USA). A value of P<0.05 was considered statistically significant.
Results
The expression of Rnd3 was downregulated in end-stage human failing hearts
The study of the role of Rnd3 in heart failure was initiated by analyzing human heart tissue 
samples. Rnd3 protein levels were measured in 12 normal and 51 human failing hearts. In 
patients with end-stage heart failure, we found a 57.9% decrease in the Rnd3 expression 
levels (Fig. 1). This clinical observation suggested that Rnd3 may act as a potential new 
regulator in the etiology of the transition to heart failure. Systemic and comprehensive 
experiments based on genetic Rnd3 knockout mice were conducted for the understanding of 
the underlying molecular mechanisms.
Rnd3 deficiency resulted in an angiogenesis defect in the mouse heart in response to 
pressure overload
Our recent study found that Rnd3 haploinsufficient (Rnd3+/−) mice were hypersensitive to 
pressure overload and developed heart failure after transverse aortic constriction (TAC) 
challenge.15 However, the severity of cardiac fibrosis and hypertrophy showed no 
significant differences between the wild-type mice and Rnd3 mutant mice (supplemental 
figure S1). To investigate the underlying molecular mechanisms, we conducted a series of 
experiments. We first analyzed cardiac capillary generation in the mouse hearts after TAC. 
Compensatory increases in the capillary area and capillary number were found in WT mice 
in response to TAC stress as expected. However, we failed to detect the responsive 
angiogenesis in Rnd3+/− mice (Fig. 2a–2b). Significantly smaller capillary areas and fewer 
capillary numbers were observed in the Rnd3 haploinsufficient mouse heart compared to the 
WT control after TAC (Fig. 2a–2b). The impaired angiogenesis was further indicated by the 
decrease in capillary/cardiomyocyte ratio (supplemental figure S2). In line with the 
morphological changes, the upregulation of endothelial-specific receptor tyrosine kinase 2 
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(Tie2) was detected in the WT mouse heart in response to TAC but not in the Rnd3+/− heart 
(Fig. 2c). To assess coronary microvascular circulation, CFR was measured. Rnd3+/− hearts 
displayed no abnormality in the microvascular function compared with WT hearts prior to 
stress (supplemental figure S3, Sham), however, a 20.8% reduction of CFR was detected in 
the Rnd3+/− heart after TAC (supplemental figure S3, TAC). Cardiac tissue hypoxia staining 
displayed a 5.9-fold increase in hypoxic areas in the Rnd3+/− heart compared to the WT 
control heart (Fig. 2d–2e). These data strongly suggested that the adaptive coronary 
angiogenesis was severely impaired in the Rnd3+/− heart in response to hemodynamic 
challenge.
Rnd3 deficiency led to the downregulation of key pro-angiogenic factors, HIF1α and 
VEGFA, in the mouse heart in response to pressure overload
HIF1α and its downstream target VEGFA are critical for responsive angiogenesis in the 
heart after stress. These factors were evaluated in order to better understand the effect of 
Rnd3 deficiency in angiogenesis. As expected, the responsive increase in levels of HIF1α 
and VEGFA proteins was detected in WT animal hearts after TAC (Fig. 3a). However, the 
responsive increase in levels of HIF1α and VEGFA proteins was not detected in Rnd3 
deficient hearts after pressure overload (Fig. 3a), which was consistent with the observation 
of impaired angiogenesis. Since VEGFA was transcriptionally regulated by transcription 
factor HIF1α, we measured VEGFA transcripts in the hearts. Again, the responsive increase 
in VEGFA by TAC was attenuated by Rnd3 deficiency (Fig. 3b).
Cardiomyocytes are the major source of VEGFA as a paracrine effector for angiogenesis in 
the heart.16, 17 To investigate the role of Rnd3 in relation with pro-angiogenic factors, we 
conducted HUVEC cell tube formation experiments by treating the cells with different 
cardiomyocyte culture media. We found that fewer tubes were developed in the culture 
media from Rnd3+/− cardiomyocytes, while the tube formation was stimulated by the media 
from the WT cardiomyocytes (Fig. 3c–3d). Significantly lower levels of VEGFA were 
detected in the Rnd3+/− cardiomyocyte culture media compared with the WT group, 
indicating downregulation of the HIF1α-VEGFA pathway in cardiomyocytes with Rnd3 
deficiency (Fig. 3e).
Rnd3 stabilized HIF1α protein and facilitated VEGFA expression
To investigate if HIF1α protein levels could be directly regulated by Rnd3, we knocked 
down and overexpressed Rnd3 in cell cultures. We found that HIF1α protein levels were 
decreased when Rnd3 was knocked down (Fig. 4a). Meanwhile, gradual increases in the 
expression levels of HIF1α were detected corresponding with incremental increases in Rnd3 
expression levels (Fig. 4b), and obvious nuclear accumulation of HIF1α protein was also 
observed (Fig. 4c). Consistent with the change in HIF1α protein levels, we detected 
increased levels of VEGFA protein when Rnd3 was overexpressed (Fig. 4b), and the 
opposite trend was detected when Rnd3 was knocked down (Fig. 4a). To further explore the 
potential mechanism involving the Rnd3-induced HIF1α stability, we conducted an in vitro 
GST-Rnd3 pull-down assay from cell lysates. As shown in Fig. 4d, Rnd3 protein bound to 
HIF1α protein, suggesting physical interaction between the two proteins. We then 
performed mutual coimmunoprecipitation assays to further illustrate the physical interaction 
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of Myc-Rnd3 and HA-HIF1α in vivo (Fig. 4e). Next, since HIF1α is a transcription factor, 
we conducted a luciferase experiment in order to determine if Rnd3 had any effects on its 
transcriptional activity. The luciferase reporter was driven by a VEGFA promoter containing 
HIF1 response elements (HREs). Hypoxic conditions were applied to induce HIF1α 
expression. Relative luciferase activity was measured under both normoxic and hypoxic 
conditions. Rnd3 knockdown resulted in an approximate 50% decline in luciferase activity 
relative to the control level in response to hypoxia (Fig. 4f). Consistent with the change in 
the HIF1α transcriptional activity, a responsive decrease in the VEGFA mRNA levels was 
detected as well (Fig. 4g), indicating that Rnd3 regulated responsive HIF1α transcriptional 
activity. Downregulation of Rnd3 weakened HIF1α transcriptional activity, leading to a 
decrease in its target gene transcripts in response to hypoxia.
Hydroxylation of HIF1α at two conserved proline residues by HIF1α prolyl hydroxylases is 
the key step to control HIF1α protein levels. Upon hydroxylation of HIF1α, it interacts with 
von-Hippel Lindau tumor-suppressor protein (VHL), therefore leading to HIF1α protein 
ubiquitination and degradation under normoxic conditions. We next evaluated the effects of 
Rnd3 on HIF1α hydroxylation. Since hydroxylated HIF1α degradation is dynamic and 
extremely fast, cell cultures with Rnd3 overexpression (Myc-Rnd3) and Rnd3 knockdown 
by siRNA (siRnd3) were first treated with MG132, a cell-permeable proteasome inhibitor, to 
block degradation of ubiquitin-conjugated proteins. Then hydroxylated HIF1α (Hydroxy-
HIF1α) levels were analyzed by Western blot. Lower levels of Hydroxy-HIF1α were 
detected in cells with Rnd3-overexpression (Fig. 4h). Consistently, increased Hydroxy-
HIF1α levels were observed under Rnd3 knockdown conditions (Fig. 4i). These data 
strengthened our hypothesis and suggested that Rnd3 stabilized HIF1α by preventing its 
hydroxylation.
CoCl2 treatment rescued Rnd3 deficiency-mediated angiogenesis defects and dilated 
cardiomyopathy in Rnd3 haploinsufficient mice after hemodynamic stress
CoCl2 is an inhibitor of prolyl hydroxylase domain-containing (PHD) protein, which is 
responsible for the hydroxylation of HIF1α, promoting its eventual degradation. Application 
of CoCl2 prevents HIF1α protein from degradation. To test if HIF1α downregulation was 
responsible for the Rnd3 deficiency-induced cardiac dysfunction and angiogenic defects, we 
treated mice with CoCl2. Improvement in cardiac function was observed in Rnd3+/− mice 
after the administration of CoCl2. Echocardiographic assessment revealed partial recoveries 
in the ejection fractions and fractional shortenings of Rnd3+/− mice with CoCl2 treatment 
compared to the mice without CoCl2 treatment (Fig. 5a). Consistent with the improved 
cardiac function, H&E staining (Fig. 5b) and cardiac echo analysis (Fig. 5c) both displayed 
less dilation in Rnd3+/− hearts with CoCl2 treatment compared to the non-treated group of 
animal hearts. The post-TAC survival rate of Rnd3+/− mice was also significantly improved 
by CoCl2 treatment (supplemental figure S4).
Finally, we analyzed protein expression levels of HIF1α and VEGFA, along with cardiac 
capillaries and cardiac CFR without CoCl2 treatment in both WT and Rnd3+/− mouse hearts. 
As expected, TAC stress induced the upregulation of HIF1α and VEGFA in WT animal 
hearts; however, the Rnd3 haploinsufficient mice failed to respond to pressure overload and 
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displayed no increase in HIF1α and VEGFA protein levels. The treatment of CoCl2 partially 
recovered the adaptive response to TAC in the Rnd3+/− animal with obvious increases in 
HIF1α and VEGFA protein levels (Fig. 5g). Isolectin staining showed improved capillary 
densities after CoCl2 applications (Fig. 5d–5e). The impaired coronary flow reserve after 
TAC was recovered by 13.6% due to CoCl2 administration (Fig. 5f).
Rnd3 overexpression attenuated the transition to heart failure by preserving responsive 
angiogenesis
We generated the transgenic Rnd3 overexpression mice (MHC-Rnd3) to further demonstrate 
the critical role of Rnd3 in angiogenesis and the hypoxic response of the heart. Elevated 
cardiac Rnd3 protein levels in the MHC-Rnd3 mice were confirmed by Western blot 
analysis (Fig. 6a). MHC-Rnd3 mice exhibited reserved cardiac function and were more 
resistant to the development of heart failure after TAC stress compared to the WT mice. In 
comparison to the WT mice from the Sham group, MHC-Rnd3 mice showed only slight 
decreases in the ejection fraction and fractional shortening percentages after TAC (Fig. 6b). 
Furthermore, the MHC-Rnd3 mice displayed a conserved LVID in systole detected by 
echocardiography compared to the WT mice after TAC surgery, indicating a resistance to 
the development of DCM due to Rnd3 overexpression (Fig. 6c). Higher coronary flow 
reserves were measured in the MHC-Rnd3 mice compared to the WT mice after TAC and 
showed no significant differences compared to the measurements from the WT Sham group, 
demonstrating preserved capillary function (Fig. 6d). In addition, more cardiac capillaries 
and larger capillary areas were visualized in the MHC-Rnd3 mice after TAC compared to 
the WT controls (Fig. 6e–6f). These findings suggested that Rnd3 upregulation can prevent 
the transition to heart failure, and Rnd3 overexpression had multiple beneficial effects under 
cardiac hypoxic conditions.
MHC-Rnd3 cardiomyocytes exhibited HIF1α-VEGFA pathway stimulation
Elevated HIF1α and VEGFA protein levels were observed, as expected, in the control WT 
mouse heart in response to TAC by Western blot. However, further increases in these two 
proteins were detected in the MHC-Rnd3 transgenic mouse heart (Fig. 7a). In order to 
determine the angiogenic effect of Rnd3 overexpression in the animal cardiomyocytes, 
HUVEC cells were treated with the media from Rnd3+/− and MHC-Rnd3 cardiomyocyte 
cultures. A significant promotion of HUVEC cell tube formation was observed in the culture 
treated with media from the MHC-Rnd3 cardiomyocytes. In addition, the previously 
observed tube formation deficiency of the cells cultured with Rnd3+/− cardiomyocyte media 
was partially rescued (Fig. 7b). The cell tube formation was quantified and analyzed by 
WimTube software, revealing more loops and branching points in the MHC-Rnd3 culture. 
Significant improvement in the total number of loops and branching points in the MHC-
Rnd3/Rnd3+/− co-culture was also observed (Fig. 7c). Lastly, VEGFA levels in the media 
from MHC-Rnd3 and WT cardiomyocyte cultures were measured by ELISA. MHC-Rnd3 
cardiomyocyte media revealed significantly higher VEGFA levels compared to the WT 
control (Fig. 7d). Taken together, cardiomyocytes from the MHC-Rnd3 mouse heart 
released more VEGFA compared to the WT control, indicating increased VEGFA paracrine 
activity and augmented angiogenesis.
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A schematic illustration of the molecular mechanism involving Rnd3 and HIF1α-VEGFA 
signaling was depicted in supplemental figure S5. Rnd3 prevented HIF1α from 
hydroxylation by stabilizing it through direct interaction, which then led to increased 
activation of the VEGF gene. Without the presence of Rnd3, increased HIF1α hydroxylation 
occurred, which facilitated HIF1α protein degradation through UPS and resulted in impaired 
angiogenesis.
Discussion
The HIF1α-VEGFA signaling pathway is the best studied molecular mechanism in the 
regulation of hypoxia/ischemia-induced angiogenesis.18 VEGFA, mainly secreted by 
cardiomyocytes in the heart,16 is the major driving force promoting endothelial cell 
proliferation during angiogenesis. HIF1 works as an αβ-heterodimer that induces 
transcriptional activation by binding to hypoxia response elements (HREs) in response to 
hypoxia. HIF1β is a constitutive nuclear protein while HIF1α is dynamically regulated. In 
normoxic conditions, HIF1α can be hydroxylated by PHD, and then quickly degraded by 
von Hippel-Lindau E3 ubiquitin ligase complex (pVHL). In the lack of oxygen, the 
hydroxylation of HIF1α is blocked, which prevents HIF1α from pVHL-mediated proteolysis 
and results in an accumulation of HIF1α protein. The latter translocates into the nuclei to 
form a transcriptional complex with HIF1β, p300, and CREB binding protein (CBP), and 
initiates the transcription of a number of genes including the VEGF family of genes (Figure 
S5).18 In this study, we demonstrated that Rnd3 functioned as a new mediator in the 
angiogenesis process by interacting with and stabilizing HIF1α, adding a new dimension to 
the regulation of the HIF complex function, which secured HIF1α-VEGFA-mediated 
angiogenesis progression during stress (Figure S5). Deficiency of Rnd3 compromised the 
HIF1α-VEGFA signaling and impaired the responsive angiogenesis. Application of CoCl2, 
a chemical that inhibits PHD and stabilizes HIF1α,19 partially rescued the Rnd3 
haploinsufficient mouse phenotype and resulted in improvement of cardiac functions and 
CFR (Figure S5).
Since drugs can have pleiotropic effects in vivo, we verified the critical role of Rnd3 in the 
heart through the use of the transgenic Rnd3 overexpression mice. Forced-expression of 
Rnd3 partially rescued the Rnd3+/− angiogenic defect both in vitro and in vivo. Interestingly, 
a recent study showed Rnd3 as a transcriptional target of HIF1α in gastric cancer cells.20 If 
the same regulation existed in the heart, there would be a forward feedback mechanism in 
which Rnd3 would stabilize HIF1α and the latter would enhance Rnd3 gene transcription.
Pathological stimuli such as hypertension, ischemia, or chronic neurohormonal 
hyperactivation are known to promote capillary growth within the myocardium.21–23 
However, the compensatory enhancement of angiogenesis in response to these pathological 
stimuli appears to be insufficient, and this insufficiency is one of the critical factors 
responsible for the transition of the heart from compensated hypertrophy to heart failure.1–4
In this study, we revealed a critical role of Rnd3 in the responsive angiogenesis process in 
the heart. We detected a 57.9% reduction of Rnd3 protein levels in end-stage human failing 
hearts. While the etiologic meaning of Rnd3 downregulation in heart failure patients remains 
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unknown, understanding the pathological consequence of Rnd3 downregulation is clearly 
important and has clinical implications. The Rnd3 haploinsufficient mouse recapitulated the 
situation observed in heart failure patients, and is a patient-relevant mouse model. 
Importantly, the mutant mice displayed impaired adaptive coronary angiogenesis that has 
not previously been linked to Rnd3 function. Given the critical role of HIF1α in pro-
angiogenic signaling, identification of its endogenous stabilizer, Rnd3, offers a new positive 
regulator toward to the HIF1α-VEGFA signaling pathway. The findings have basic and 
clinical significance. The Rnd3 mutant mice provide a patient-relevant animal model for 
further mechanistic investigation.
Rnd3 was originally identified as a repressor of Rho signaling by either directly binding to 
Rho-associated coiled-coil protein kinase 1 (ROCK1) or indirectly targeting RhoA through 
p190-B RhoGAP.24–27 The importance of Rho kinase ROCK 1 in the heart has been 
investigated by our lab as well as by other groups.28–32 We demonstrated that ROCK1-null 
mice were resistant to pressure overload-induced injury and fibrotic response.30 In human 
patients, we first found that ROCK1 was a caspase-3 target. The cleavage of ROCK1 by 
caspase-3 generated a constitutively active isoform of Rho kinase fragment that was 
accumulated in human failing hearts.28 The transgenic mice with forced expression of this 
cleaved ROCK1 isoform led to fibrotic cardiomyopathy. Treatment with Rho kinase 
inhibitor reversed the cardiac phenotype and improved cardiac functions.29 Therefore, it wa 
logical to assume that the Rnd3 deficiency-mediated cardiac dysfunction was through the 
augmentation of ROCK1 activity. However, by taking the approaches of genetic deletion of 
ROCK1 and the utilization of a Rho kinase inhibitor, we recently found that Rho kinase 
activation was partially, but not entirely, responsible for Rnd3 deficiency-induced 
cardiomyopathy, suggesting that there was a Rho kinase-independent mechanism regulated 
by Rnd3.15
Perspectives
This study extended the previous observation and uncovered a new function of Rnd3, in 
which Rnd3 participated in the regulation of responsive angiogenesis. The downregulation 
of Rnd3 resulted in an angiogenic response defect in the animal heart, contributing to the 
transition to heart failure. The associated molecular mechanism was conceived that Rnd3 
bound to HIF1α, and stabilized HIF1α through the inhibition of its hydroxylation and 
prevented the protein from degradation. Downregulation of Rnd3 resulted in an increase in 
HIF1α hydroxylation and a subsequent decrease in its protein levels; which in turn impaired 
HIF-VEGF signaling and attenuated responsive angiogenesis progression. The findings 
uncovered a new function of this small GTPase in the refinement of the HIF1α-VEGFA 
regulatory pathway, and provided a potentially new target of pharmacological manipulation 
for HIF1α-VEGF signaling. The assessment of Rnd3 expression levels in patients could be a 
new reference biomarker for human heart failure.
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Novelty and Significance
1) What is New?
This study uncovered previously undescribed function of Rnd3 and revealed the 
associated molecular mechanism, which Rnd3 was as a novel pro-angiogenic factor 
involved in cardiac responsive angiogenesis through HIF1α-VEGFA signaling 
promotion. A significant decrease level of Rnd3 protein was detected in human failing 
myocardia. Genetic deletion of Rnd3 in mice impaired angiogenic response in heart in 
response to pressure overload.
2) What is Relevant?
Neovascularization is a compensatory mechanism in heart in response to hypertension. 
The insufficiency of compensatory angiogenesis in heart in hypertension patients 
contributes to the transition to heart failure.
3) Summary
This study demonstrated a pro-angiogenic role of Rnd3 through the regulation of the 
HIF1α-VEGFA signaling pathway. The decrease in Rnd3 expression levels contributed 
to the insufficiency of adaptive coronary angiogenesis in the mouse heart in response to 
pressure overload. The finding of the significant downregulation of Rnd3 in myocardia of 
heart failure patients implicated the translational and clinical significance of this 
discovery.
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Figure 1. Rnd3 protein levels were decreased in human failing hearts
(a) Representative Rnd3 protein expression by Western blot analysis. (b) Quantification of 
Rnd3 protein expression levels from 12 normal and 51 failing myocardia.
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Figure 2. Rnd3 deficiency resulted in an angiogenesis defect in the mouse heart in response to 
TAC
(a) Fewer capillaries were observed in the post-TAC Rnd3+/− heart by isolectin staining 
shown in green. Blue indicated nuclear DAPI staining. Scale bar represents 12.5 µm. (b) 
Cardiac capillaries were quantified by LAS V4.0 software (Germany). Smaller capillary 
areas and fewer capillary numbers were observed in the Rnd3+/− mouse heart compared to 
the WT control after TAC. (c) The responsive increases in angiogenic marker Tie2 mRNA 
and protein levels were attenuated in the post-TAC Rnd3+/− heart. (d) Larger hypoxic areas 
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were detected in the Rnd3+/− heart compared to the WT heart after TAC. Hypoxyprobe™-1 
staining (brown) showed hypoxic myocardium. Scale bar represents 50 µm. (e) 
Quantification of hypoxic areas by LAS 4.0 software (Germany). The numbers in the 
columns represented the number of mice in each group.
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Figure 3. HIF1α-VEGFA pathway was downregulated in the Rnd3+/− heart in response to TAC
(a) Downregulation of HIF1α and VEGFA protein in the Rnd3+/− heart in response to TAC 
was shown by Western blot analysis. (b) The responsive increase in VEGFA mRNA levels 
was significantly attenuated in the Rnd3+/− heart after TAC. (c) HUVEC cell tube formation 
was promoted by the media from the WT cardiomyocytes, while fewer tubes were 
developed in the culture media from the Rnd3+/− cardiomyocytes. Scale bar represents 500 
µm. (d) The tube formation was quantified by WimTube software. (e) Cardiomyocytes from 
the Rnd3+/− heart released less VEGFA compared to control WT cardiomyocytes, indicating 
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weak VEGFA paracrine activity. The numbers in the columns represented the number of 
mice in each group.
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Figure 4. Rnd3 bound to HIF1α, prevented HIF1α protein from hydroxylation and stabilized the 
protein, which in turn promoted VEGFA expression
(a) Downregulation of Rnd3 resulted in lower HIF1α and VEGFA protein expression. (b) 
The incremental increases in the expression levels of HIF1α and VEGFA protein were 
observed when Rnd3 was gradually overexpressed. (c) HIF1α nuclear accumulation was 
displayed when cells overexpressed Rnd3. Scale bar represents 50 µm. (d) HIF1α was pulled 
down by GST-Rnd3 protein in vitro. (e) Myc-Rnd3 physically interacted with HA-HIF1α in 
vivo evidenced by mutual coimmunoprecipitations. (f) Rnd3 deficiency weakened HIF1α 
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transcriptional activity demonstrated by luciferase assays. (g) The qPCR analysis showed 
that VEGFA mRNA levels did not increase in the cells with Rnd3 deficiency in response to 
hypoxia. (h) Rnd3 overexpression in cells reduced hydroxylation of HIF1α. (i) Knockdown 
of Rnd3 led to an increase in Hydroxy-HIF1α levels. MG132: a proteasome inhibitor.
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Figure 5. Rnd3 deficiency-mediated angiogenesis defect and dilated cardiomyopathy were 
attenuated by CoCl2 admission
(a) The repressed ejection fractions and fractional shortenings of the Rnd3+/− mice after 
TAC were significantly improved by CoCl2 treatment assessed by echocardiography. Along 
with the improved cardiac function, the enlarged ventricle chamber phenotype was lessened; 
displayed by the heart sections with H&E staining (b), and confirmed by echocardiography 
analysis (c). Scale bar represents 1 mm. (d) Isolectin staining showed an increased number 
of capillaries (green) in the post-TAC Rnd3+/− heart after CoCl2 treatment. Scale bar 
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represents 12.5 µm. (e) The improvement of capillary density was quantified (LAS V4.0 
software, Germany) and presented as capillary number and capillary area. Nuclear DAPI 
staining was shown in blue. (f) The reduced coronary flow reserve in the Rnd3+/− mice after 
TAC was recovered by CoCl2 administration. (g) Immunoblots revealed increased HIF1α 
and VEGFA protein expression levels after CoCl2 treatment in both Rnd3+/− and WT mouse 
hearts. LVIDs: left ventricular internal dimension in systole. The numbers in the columns 
represented the number of mice in each group.
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Figure 6. Cardiac specific overexpression of Rnd3 protected the heart from the transition to 
heart failure by preserving responsive angiogenesis
(a) Representative Rnd3 protein expression levels in the hearts of WT and Rnd3 transgenic 
(MHC-Rnd3) mice by Western blot analysis. (b) MHC-Rnd3 mice have reserved cardiac 
function and developed less severe heart failure after TAC. Only slight decreases in the 
cardiac ejection fractions and fractional shortenings were detected in MHC-Rnd3 mice after 
TAC compared to WT mice from the Sham group. (c) No significant increase in the LVID 
in systole was detected by echocardiography in MHC-Rnd3 mice after TAC compared to the 
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Sham WT mice. (d) MHC-Rnd3 mice have preserved capillary function after TAC 
compared to WT mice. (e) More capillaries were observed in the post-TAC MHC-Rnd3 
mouse heart by isolectin staining (green). (f) Larger capillary areas and more capillary 
numbers were observed in the MHC-Rnd3 mouse heart compared to the WT control after 
TAC. Cardiac capillaries were quantified by LAS V4.0 software (Germany). The numbers in 
the columns represented the number of mice in each group.
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Figure 7. HIF1α-VEGFA signaling was enhanced in MHC-Rnd3 cardiomyocytes
(a) Upregulation of HIF1α and VEGFA protein levels in the MHC-Rnd3 mouse heart in 
response to TAC was shown by Western blot analysis. (b) HUVEC cell tube formation was 
highly promoted by the media from the MHC-Rnd3 cardiomyocytes. The resulting tube 
formation deficiency from culturing with the Rnd3+/− cardiomyocyte media was partially 
rescued when co-cultured with the MHC-Rnd3 cardiomyocyte media. Scale bar represents 
500 µm. (c) The tube formation was quantified by WimTube software. (d) Cardiomyocytes 
from the MHC-Rnd3 heart released more VEGFA compared to the control WT 
Yue et al. Page 23
Hypertension. Author manuscript; available in PMC 2017 March 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
cardiomyocytes, indicating strong VEGFA paracrine activity. The numbers in the columns 
represented the number of mice in each group.
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